Inactive Instrument

Square Pharmaceuticals Ltd Stock Dhaka S.E.

Equities

Pharmaceuticals

End-of-day quote Dhaka S.E.
- BDT - Intraday chart for Square Pharmaceuticals Ltd
Sales 2024 * 71.99B 655M Sales 2025 * 81.08B 737M Capitalization 187B 1.7B
Net income 2024 * 21.5B 195M Net income 2025 * 24.67B 224M EV / Sales 2024 * 2.6 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.31 x
P/E ratio 2024 *
8.82 x
P/E ratio 2025 *
7.58 x
Employees -
Yield 2024 *
4.86%
Yield 2025 *
5.33%
Free-Float 64.82%
More Fundamentals * Assessed data
Square Pharmaceuticals PLC. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Square Pharmaceuticals PLC. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Square Pharmaceuticals PLC. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Square Pharmaceuticals PLC. Recommends Cash Dividend for the Year Ended June 30, 2023 CI
Square Pharmaceuticals PLC Announces Contract Manufacturing Agreement with M/S Aristopharma Ltd CI
Square Pharmaceuticals Limited has Changed its Name to Square Pharmaceuticals PLC CI
Square Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Square Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Square Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Square Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 CI
Square Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
Square Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
Square Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021 CI
Square Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021 CI
Square Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020 CI
More news
Managers TitleAgeSince
Chief Executive Officer - 79-12-31
Director of Finance/CFO - -
Compliance Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 79-12-31
Chairman - 90-12-31
Director/Board Member - 90-12-31
More insiders
Square Pharmaceuticals PLC. is a Bangladesh-based pharmaceutical company. The Company's products include pharma, herbal and nutraceutical, and agrovet and crop care. The Company's pharma products include Ace, Ace Plus, Ace Power, Aclitol Cozycap, Adryl, Acetram, Afun, Akicin, Alacot DS Eye Drops, Alacot Eye Drops, Alacot Max Eye Drops, Alarid Eye Drops, Alarid, Alice Lotion, Amodis 500 IV, Asynta Max, Avaspray, Axlovir Combipack, Ansulin Pen Cartridge, Angilock Plus, Clopirox Cream, Clopirox Shampoo, Contilex TS, Germisol Hand Rub, Glycovent Nebuliser Solution, Glysup, Gynepro and K-One MM. Its herbal and nutraceutical products include AmCivit, Antiscar, Arubin, Betaburn, Bioprem, Bolardi, Femony, Fitvit, Flemo Max, Flemo, Flemo Plus, Freezy, Lecor, Livolite, Maximilk, Monera, Redclov, Reli Balm, Revatol, Toco Soft, Torel, Trumega and ZanthinTM Softgel Capsule. Its agrovet and crop care products include Ace-Vet Bolus, Agrizeb 80 WP, Aqua Rock, Almex-Vet Bolus and Andopan Powder.
More about the company